Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2025	Mar. 31, 2024
ASSETS
Cash and cash equivalents	$ 10,769	$ 8,570
Restricted cash and cash equivalents	2,490	2,251
Investments in marketable securities	4,581	4,505
Finance receivables, net of allowance for credit losses of $1,644 and $1,637, respectively	101,749	101,669
Investments in operating leases, net	30,090	28,013
Other assets	5,615	4,373
Total assets	155,294	149,381
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	127,745	122,420
Deferred income taxes	2,973	3,272
Other liabilities	7,333	6,707
Total liabilities	138,051	132,399
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at March 31, 2025 and 2024	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(56)	(65)
Retained earnings	16,382	16,130
Total shareholder's equity	17,243	16,982
Total liabilities and shareholder's equity	$ 155,294	$ 149,381